Director dealings: Idox CEO makes share sale.


Idox revealed on Wednesday that chief executive David Meaden had disposed of 3.29m ordinary shares in the AIM-listed software and solutions firm.

Source: Sharecast

Meaden, who also excercised options over 1.83m Idox shares, sold the stock at an average price of 71.5p each, for a total value of £2.35m.

As of 1445 BST, Idox shares were down 0.25% at 71.42p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Gunsynd (GUN)
Director name: Strang,Donald
Amount purchased: 4,000,000 @ 0.11p
Value: £4,400.00

On The Beach Group (OTB)
Director name: Morton,Shaun
Amount purchased: 991 @ 184.67p
Value: £1,830.08

Top Director Sells

Idox (IDOX)
Director name: Meaden,David
Amount sold: 3,290,842 @ 71.50p
Value: £2,352,951.94

Idox (IDOX)
Director name: Legdon,Jonathan
Amount sold: 2,174,969 @ 71.50p
Value: £1,555,102.78

Idox (IDOX)
Director name: Stone,Christopher M R
Amount sold: 1,521,877 @ 71.50p
Value: £1,088,142.02

Idox (IDOX)
Director name: Kang,Anoop
Amount sold: 1,458,699 @ 71.50p
Value: £1,042,969.75

Frontier Developments (FDEV)
Director name: Braben ,David John
Amount sold: 50,000 @ 390.00p
Value: £195,000.00

Idox (IDOX)
Director name: Kelly,Philip
Amount sold: 105,263 @ 71.50p
Value: £75,263.04


ISIN: GB0002998192
Exchange: London Stock Exchange
Sell:
71.20 p
Buy:
71.60 p
Change: 0.40 ( 0.56 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.